Sidney Kimmel Cancer Center makes personnel changes

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

SIDNEY KIMMEL CANCER CENTER at Johns Hopkins University made several personnel changes.

Kenneth Cohen was named associate director of integration and strategic relationships for the Department of Oncology. In this role, Cohen will work with faculty members and administration to represent the interests of the department and the Cancer Center in discussions and negotiations with outside entities.

Charles Drake was appointed co-director of the Kimmel Cancer Center’s Immunology Program. He joins Drew Pardoll in leading the program. In addition to his research responsibilities, Drake is a clinical oncologist specializing in prostate, kidney, bladder and testicular cancers.

Khinh Ranh Voong has been appointed instructor in the Department of Radiation Oncology and Molecular Radiation Sciences, where she will be a part of the thoracic oncology team based at Johns Hopkins Bayview Medical Center.

Syed Ali was appointed as an instructor in oncology for the Division of Hematologic Malignancies. Ali will focus on novel and immune-based approaches for the treatment of multiple myeloma. He will serve as an attending on the inpatient hematologic malignancy service, supervise fellows’ clinic, participate in bone marrow reading and see patients in clinic.

Nilanjan Chatterjee has joined the faculty as a Bloomberg Distinguished Professor with a dual appointment in the Department of Oncology’s Division of Biostatistics and Bioinformatics and in the Department of Biostatistics at the Bloomberg School of Public Health.

Doug Smith, of the Department of Oncology’s Division of Hematologic Malignancies, was promoted to professor of oncology.

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login